Skip to content

Biomarkers for Peripheral Circadian Clocks in Humans

Biomarkers for Peripheral Circadian Clocks in Humans

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06296823
Enrollment
14
Registered
2024-03-06
Start date
2023-09-01
Completion date
2027-08-31
Last updated
2026-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circadian Rhythms

Brief summary

The purpose of this project is to improve our understanding of peripheral circadian rhythms in humans. Circadian clocks are present in most tissues of the body with importance for optimal physiological function, health, and behavior. This project will utilize simulated jetlag protocols to systematically test novel hypotheses about the regulation of peripheral circadian rhythms in humans. Specifically, we will examine how changes in the time of when we are exposed to light and the timing of when we eat impacts proteins in the blood and saliva that represent rhythms from clocks in the brain (e.g., rhythms of the hormones melatonin and cortisol coordinated by the brain) and rhythms from clocks in body tissues (e.g., proteins made by immune and bone cells, and cells in the stomach and liver). We also aim to discover new blood-based biomarkers of peripheral rhythms in humans. We anticipate our findings will be the first step in developing novel circadian based treatments for aligning peripheral clocks under conditions such as jetlag, and for developing novel circadian biomarkers that will advance our scientific understanding of circadian rhythms.

Detailed description

Visit 1: Participants who meet pre-screen/initial inclusion criteria will be consented at Visit 1, complete additional questionnaires and interviews to assess inclusion/exclusion criteria, and we will collect descriptive data as well as have our clinical psychologist perform a clinical interview. Visit 2: Participants will undergo medical screening at the Clinical Translational Research Center at the University of Colorado Boulder (UCB-CTRC) to determine health status. Visits 3 & 6: Participants will be asked to maintain a regular \ 8h sleep-wake schedule for two weeks prior to Visits 5 and 8. Participants will wear a wrist activity, skin temperature, and light exposure recorder. Participants will be asked to remain in the local time zone during ambulatory recording procedures and be asked to keep their typical schedules (e.g., not stay up all night for work or social events and not reside in a new place different from their place of residence). Visit 4 & 7: Participants will come to the laboratory on days 11 and 39, where qualified staff will apply a Continuous Glucose Monitoring (CGM) sensor to be worn for \ 3 days at home and will continue in the laboratory. For the three days leading up to the study isocaloric meals including breakfast, lunch, and dinner will be provided. Participants will be asked to consume these energy balanced research diets (no caffeine) and meal timing will be scheduled (breakfast \ 30 min, lunch \ 5h, and dinner \ 10h after awakening,). Exercise will be proscribed for these 3-days prior to the in-lab study. Visits 5 & 8: Participants will be randomized to condition order using an ABBA design (i.e., randomized into one of the two experimental conditions first in a crossover design: 3-days bright light exposure or 3-days of earlier timed meals). Both conditions are tested under an advanced sleep-wake schedule equivalent to traveling 5 time zones east. All participants will complete both conditions. On the second visit, participants will be tested in the other condition. Participants will live in the laboratory for 7.7 days each visit.

Interventions

BEHAVIORALSimulated jetlag protocol

16 hours of wakefulness and an 8 hour scheduled sleep opportunity in a simulated jetlag protocol where you will go to bed and awaken earlier than usual.

Sponsors

University of Colorado, Boulder
Lead SponsorOTHER
University of Colorado, Denver
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
17 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

1\) 17-35 years old 2) English speaking 3) Healthy 5) Altitude history: Currently residing at Denver altitude or higher

Exclusion criteria

1\. Any medical, psychiatric, or sleep disorder.

Design outcomes

Primary

MeasureTime frameDescription
PYYhourly for up to 25 hours on two occasionsAppetitive hormone-promotes satiety
Ghrelinhourly for up to 25 hours on two occasionsAppetitive hormone-promotes food intake
Leptinhourly for up to 25 hours on two occasionsAppetitive hormone-promotes satiety
CRPhourly for up to 25 hours on two occasionsAcute phase response/also marker of inflammation
OMDhourly for up to 25 hours on two occasionsBiomineralization
PAI-1hourly for up to 25 hours on two occasionsInhibitor of fibrinolysis
IgEhourly for up to 25 hours on two occasionsImmune responses to parasites and allergens
CCL18hourly for up to 25 hours on two occasionsChemotaxis / immune cell trafficking
PTHhourly for up to 25 hours on two occasionsSerum calcium homeostasis

Secondary

MeasureTime frameDescription
Glucosecontinuously for up to 35 hours on two occasionsBlood sugar
Insulinhourly for up to 25 hours on two occasionshormone that helps regulated blood glucose levels
Proteomicshourly for up to 25 hours on two occasionsproteins

Countries

United States

Contacts

CONTACTKenneth Wright, PhD
sleep.study@colorado.edu303-735-1923

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 18, 2026